Jaime E. Hernández

Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults

Edwin DeJesus, Gisela Herrera, Eugénio Teófilo et al. · Clinical Infectious Diseases · 2004 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study

Grace A. McComsey, Douglas Ward, Siegrid M. Hessenthaler et al. · Clinical Infectious Diseases · 2004 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects

Cindy Brothers, Jaime E. Hernández, Amy Cutrell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 182 citations

Medicine, Cardiology, Pharmacology +15

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

Grace A. McComsey, D. Paulsen, J Tyler Lonergan et al. · AIDS · 2004 · 171 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States

Jaime E. Hernández, Raghavendra Adiga, Robert W. Armstrong et al. · Clinical Infectious Diseases · 2011 · 93 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +8